Dow Up0.51% Nasdaq Up0.24%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
15.73 Down 0.05(0.32%) Nov 21, 4:00PM EST
|After Hours : 15.63 Down 0.10 (0.64%) Nov 21, 6:18PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 14,219   37,329   46,990  
Cost of Revenue -   -   -  
Gross Profit 14,219   37,329   46,990  
Operating Expenses
Research Development72,909  52,402  66,862  
Selling General and Administrative31,594  14,630  16,055  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (90,284) (29,703) (35,927)
Income from Continuing Operations
Total Other Income/Expenses Net(22,027)(91,938)33,022  
Earnings Before Interest And Taxes(111,985)(121,287)(2,318)
Interest Expense -   -   -  
Income Before Tax(111,985)(121,287)(2,318)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(111,985)(121,287)(2,318)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (111,985) (121,287) (2,318)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (111,985) (121,287) (2,318)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.